BIOMAT Database Logo BIOMAT Database Logo

[Clinical studies on cefprozil in pediatrics]. 1992

T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
Department of Pediatrics, Takamatsu Red Cross Hospital.

Cefprozil (CFPZ, BMY-28100) fine granules were given orally to 21 children with acute bacterial infections including 15 cases of acute tonsillitis and 3 each of acute bronchitis and urinary tract infections. Good to excellent clinical responses were obtained in 19 of the 21 patients and bacterial eradications were obtained for all 11 strains found in these cases. Loose stool and eosinophilia were observed in 1 case each. From the above clinical results, it appears that CFPZ is a useful antibiotic for the treatment of pediatric patients with various bacterial infections.

UI MeSH Term Description Entries
D008297 Male Males
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097670 Cefprozil A second-generation cephalosporin antibacterial agent. Cefprozil has a phenyl ring at the C-3 position of its cephalosporin core. Cefprozil Monohydrate,Cefprozil Sulfate,Arzimol,BMY 28100,BMY-28100,Brisoral,Cefzil,Procef,28100, BMY,Monohydrate, Cefprozil,Sulfate, Cefprozil

Related Publications

T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Clinical studies on cefprozil granules in pediatrics].
November 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Basic and clinical studies on cefprozil in pediatrics].
December 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Laboratory and clinical studies on cefprozil granules in pediatrics].
November 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Clinical study on cefprozil in pediatrics].
November 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Laboratory and clinical studies on cefprozil in the field of pediatrics].
November 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Clinical studies on cefprozil granules].
December 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Clinical evaluation of a new oral cephalosporin, cefprozil, in pediatrics].
December 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Pharmacokinetic study on oral antibiotics in pediatrics. III. A pharmacokinetic study on cefprozil in pediatrics].
November 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Pharmacokinetic, bacteriological and clinical studies on cefprozil in pediatric patients].
November 1992, The Japanese journal of antibiotics,
T Sekiguchi, and Y Shiino, and K Murakawa, and M Nishimori, and H Kouzan, and K Ohara, and T Okamoto
[Pharmacokinetic and clinical studies on cefprozil granules in the pediatric field].
December 1992, The Japanese journal of antibiotics,
Copied contents to your clipboard!